1 |
Huang SF, Peng XF, Jiang L, Hu CY, Ye WC. LncRNAs as Therapeutic Targets and Potential Biomarkers for Lipid-Related Diseases. Front Pharmacol 2021;12:729745. [PMID: 34421622 DOI: 10.3389/fphar.2021.729745] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Li J, Zhang Y, Zhang D, Li Y. The Role of Long Non-coding RNAs in Sepsis-Induced Cardiac Dysfunction. Front Cardiovasc Med 2021;8:684348. [PMID: 34041287 DOI: 10.3389/fcvm.2021.684348] [Reference Citation Analysis]
|
3 |
Liu Z, Zhang Z, Song G, Wang X, Xing H, Wang C, Meccariello R. Resveratrol Alleviates Skeletal Muscle Insulin Resistance by Downregulating Long Noncoding RNA. International Journal of Endocrinology 2022;2022:1-16. [DOI: 10.1155/2022/2539519] [Reference Citation Analysis]
|
4 |
Xu Y, Chen J, Wang M, Yu R, Zou W, Shen W. Mechanism of lncRNA-ANRIL/miR-181b in autophagy of cardiomyocytes in mice with uremia by targeting ATG5. PLoS One 2021;16:e0256734. [PMID: 34469488 DOI: 10.1371/journal.pone.0256734] [Reference Citation Analysis]
|
5 |
Garratt H, Ashburn R, Sopić M, Nogara A, Caporali A, Mitić T. Long Non-Coding RNA Regulation of Epigenetics in Vascular Cells. Noncoding RNA 2021;7:62. [PMID: 34698214 DOI: 10.3390/ncrna7040062] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|